KRED

Tuesday, May 16, 2017

INVO Bioscience Reports First Quarter 2017 Financial Results

http://ift.tt/2qKylJ4

INVO Bioscience (IVOB) is a medical device company, headquartered in Medford, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology.MEDFORD, Mass., May 15, 2017 /PRNewswire/ — INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced its first quarter financial results and recent highlights.
Recent Highlights…

May 16, 2017 at 01:30AM

http://ift.tt/2pPUrFs

from

http://ift.tt/2pPUrFs